Gene · 5144
Papers2,257
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,257
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Novel Azaindole Compounds as Phosphodiesterase 4B Inhibitors for Treating Immune-Inflammatory Diseases or Disorders. | ACS Med Chem Lett | 2025 | 40365387 | PubTator, text mining | PubMed |
| The Importance of Mitochondrial Processes in the Maturation and Acquisition of Competences of Oocytes and Embryo Culture. | Int J Mol Sci | 2025 | 40362337 | PubTator, text mining | PubMed |
| Dialkyloxyphenyl hybrids as PDE4B inhibitors: Design, synthesis, in vitro/in vivo anti-inflammatory activity and in silico insights. | Bioorg Chem | 2025 | 40311245 | PubTator, text mining | PubMed |
| The Missing Enzymes: A Call to Update Pharmacological Profiling Practices for Better Drug Safety Assessment. | J Med Chem | 2025 | 40173276 | PubTator, text mining | PubMed |
| Role of PDE4 Family in Cardiomyocyte Physiology and Heart Failure. | Cells | 2025 | 40136709 | PubTator, text mining | PubMed |
| Probing the dark chemical matter against PDE4 for the management of psoriasis using in silico, in vitro and in vivo approach. | Mol Divers | 2025 | 40095248 | PubTator, text mining | PubMed |
| PDE4D inhibition ameliorates cardiac hypertrophy and heart failure by activating mitophagy. | Redox Biol | 2025 | 40015131 | PubTator, text mining | PubMed |
| Identification of 16 novel Alzheimer's disease loci using multi-ancestry meta-analyses. | Alzheimers Dement | 2025 | 39998322 | PubTator, text mining | PubMed |
| Inhibition of GRK2-PDE4D Axis Suppresses Fibroblast-Like Synoviocytes Hyperplasia and Alleviates Experimental Arthritis. | Int J Biol Sci | 2025 | 39990667 | PubTator, text mining | PubMed |
| 5-hydroxymethylcytosine features of portal venous blood predict metachronous liver metastases of colorectal cancer and reveal phosphodiesterase 4 as a therapeutic target. | Clin Transl Med | 2025 | 39956959 | PubTator, text mining | PubMed |
| The genetic landscape of early-onset Alzheimer's disease in China. | Alzheimers Dement | 2025 | 39907198 | PubTator, text mining | PubMed |
| Phosphodiesterase 4 inhibition as a novel treatment for stroke. | PeerJ | 2025 | 39897494 | PubTator, text mining | PubMed |
| A rare case of acrodysostosis type 2 with PDE4D mutation in a young female: a case report. | Oxf Med Case Reports | 2025 | 39834885 | PubTator, text mining | PubMed |
| Protein kinase a suppresses antiproliferative effect of interferon-α in hepatocellular carcinoma by activation of protein tyrosine phosphatase SHP2. | J Biol Chem | 2025 | 39826687 | PubTator, text mining | PubMed |
| Phosphodiesterase 4D inhibition improves the functional and molecular outcome in a mouse and human model of Charcot Marie Tooth disease 1 A. | Biomed Pharmacother | 2025 | 39823724 | PubTator, text mining | PubMed |
| De novo generation of dual-target compounds using artificial intelligence. | iScience | 2025 | 39801837 | PubTator, text mining | PubMed |
| The promise of cyclic AMP modulation to restore cognitive function in neurodevelopmental disorders. | Curr Opin Neurobiol | 2025 | 39740265 | PubTator, text mining | PubMed |
| Genome-wide association study on chronic postsurgical pain after abdominal surgeries in the UK Biobank. | Anaesthesia | 2025 | 39734325 | PubTator, text mining | PubMed |
| Inhibition of the upregulated phosphodiesterase 4D isoforms improves SERCA2a function in diabetic cardiomyopathy. | Br J Pharmacol | 2025 | 39662482 | PubTator, text mining | PubMed |
| Network pharmacology and metabolomics elucidate the underlying effects and mechanisms of maackiain against endometrial cancer. | Biochem Biophys Res Commun | 2025 | 39657356 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5144/papers?page=5